PHAT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Phathom Pharmaceuticals Inc (PHAT).


$555.22M Market Cap.

As of 03/06/2025 5:00 PM ET (MRY) • Disclaimer

PHAT Market Cap. (MRY)


PHAT Shares Outstanding (MRY)


PHAT Assets (MRY)


Total Assets

$378.32M

Total Liabilities

$631.90M

Total Investments

$0

PHAT Income (MRY)


Revenue

$55.25M

Net Income

-$334.33M

Operating Expense

$324.75M

PHAT Cash Flow (MRY)


CF Operations

-$266.77M

CF Investing

-$135.00K

CF Financing

$182.77M

PHAT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

PHAT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$378,318,000 (-8.58%)

$413,842,000 (151.10%)

$164,810,000 (-13.00%)

$189,431,000 (-35.81%)

Assets Current

$360,134,000 (-9.38%)

$397,432,000 (147.60%)

$160,512,000 (-13.95%)

$186,526,000 (-35.98%)

Assets Non-Current

$18,184,000 (10.81%)

$16,410,000 (281.81%)

$4,298,000 (47.95%)

$2,905,000 (-22.39%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

-$253,580,000 (-248.52%)

-$72,759,000 (2.75%)

-$74,814,000 (-203.68%)

$72,156,000 (-62.86%)

Property Plant & Equipment Net

$2,089,000 (-42.31%)

$3,621,000 (3.63%)

$3,494,000 (36.27%)

$2,564,000 (-23.67%)

Cash & Equivalents

$300,125,000 (-21.89%)

$384,256,000 (146.49%)

$155,890,000 (-15.01%)

$183,419,000 (-36.20%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$14,748,000 (56.20%)

$9,442,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$38,797,000 (2270.01%)

$1,637,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$10,507,000 (-16.62%)

$12,601,000 (26.05%)

$9,997,000 (94.12%)

$5,150,000 (-69.31%)

Accumulated Retained Earnings (Deficit)

-$1,263,011,000 (-36.00%)

-$928,685,000 (-27.73%)

-$727,093,000 (-37.35%)

-$529,370,000 (-37.32%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$535,171,000 (21.95%)

$438,846,000 (112.42%)

$206,595,000 (126.18%)

$91,341,000 (86.34%)

Debt Current

$501,000 (-30.99%)

$726,000 (2.54%)

$708,000 (45.38%)

$487,000 (-93.78%)

Debt Non-Current

$534,670,000 (22.04%)

$438,120,000 (112.80%)

$205,887,000 (126.61%)

$90,854,000 (120.57%)

Total Liabilities

$631,898,000 (29.86%)

$486,601,000 (103.07%)

$239,624,000 (104.33%)

$117,275,000 (16.30%)

Liabilities Current

$85,728,000 (121.06%)

$38,781,000 (47.81%)

$26,237,000 (38.67%)

$18,921,000 (-65.92%)

Liabilities Non-Current

$546,170,000 (21.96%)

$447,820,000 (109.86%)

$213,387,000 (116.96%)

$98,354,000 (117.04%)

PHAT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$55,252,000 (8001.47%)

$682,000 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$7,973,000 (4674.25%)

$167,000 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$290,664,000 (146.48%)

$117,928,000 (16.76%)

$100,999,000 (60.98%)

$62,742,000 (128.01%)

Research & Development Expense

$34,082,000 (-31.70%)

$49,899,000 (-30.15%)

$71,441,000 (-1.24%)

$72,338,000 (-26.30%)

Operating Expenses

$324,746,000 (93.50%)

$167,827,000 (-2.68%)

$172,440,000 (27.66%)

$135,080,000 (7.49%)

Interest Expense

$72,009,000 (71.58%)

$41,968,000 (53.70%)

$27,305,000 (302.25%)

$6,788,000 (48.18%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$334,326,000 (-65.84%)

-$201,592,000 (-1.96%)

-$197,723,000 (-37.42%)

-$143,883,000 (-11.48%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$334,326,000 (-65.84%)

-$201,592,000 (-1.96%)

-$197,723,000 (-37.42%)

-$143,883,000 (-11.48%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$334,326,000 (-65.84%)

-$201,592,000 (-1.96%)

-$197,723,000 (-37.42%)

-$143,883,000 (-11.48%)

Weighted Average Shares

$63,176,210 (23.18%)

$51,289,092 (31.11%)

$39,118,215 (5.72%)

$37,002,959 (11.36%)

Weighted Average Shares Diluted

$63,176,210 (23.18%)

$51,289,092 (31.11%)

$39,118,215 (5.72%)

$37,002,959 (11.36%)

Earning Before Interest & Taxes (EBIT)

-$262,317,000 (-64.33%)

-$159,624,000 (6.33%)

-$170,418,000 (-24.31%)

-$137,095,000 (-10.13%)

Gross Profit

$47,279,000 (9080.39%)

$515,000 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$277,467,000 (-65.84%)

-$167,312,000 (2.97%)

-$172,440,000 (-27.66%)

-$135,080,000 (-7.49%)

PHAT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$135,000 (91.74%)

-$1,634,000 (-56.96%)

-$1,041,000 (-217.38%)

-$328,000 (68.46%)

Net Cash Flow from Financing

$182,774,000 (-50.28%)

$367,580,000 (206.21%)

$120,042,000 (168.50%)

$44,708,000 (-60.94%)

Net Cash Flow from Operations

-$266,770,000 (-93.90%)

-$137,580,000 (6.11%)

-$146,530,000 (1.30%)

-$148,457,000 (-113.03%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$84,131,000 (-136.84%)

$228,366,000 (929.55%)

-$27,529,000 (73.55%)

-$104,077,000 (-337.99%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$135,000 (91.74%)

-$1,634,000 (-56.96%)

-$1,041,000 (-217.38%)

-$328,000 (68.46%)

Issuance (Repayment) of Debt Securities

$59,400,000 (-71.98%)

$211,993,000 (122.11%)

$95,446,000 (123.19%)

$42,764,000 (71.06%)

Issuance (Purchase) of Equity Shares

$123,374,000 (-20.70%)

$155,587,000 (532.57%)

$24,596,000 (1165.23%)

$1,944,000 (-97.83%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$24,047,000 (-46.59%)

$45,025,000 (86.57%)

$24,133,000 (43.55%)

$16,812,000 (187.88%)

Depreciation Amortization & Accretion

$795,000 (38.26%)

$575,000 (-7.26%)

$620,000 (19.00%)

$521,000 (61.30%)

PHAT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

85.60% (13.38%)

75.50%

-

-

Profit Margin

-605.10% (97.95%)

-29558.90%

-

-

EBITDA Margin

-473.30% (97.97%)

-23321.00%

-

-

Return on Average Equity (ROAE)

162.50% (-67.13%)

494.30% (-56.12%)

1126.60% (1024.20%)

-121.90% (-76.67%)

Return on Average Assets (ROAA)

-92.80% (-21.94%)

-76.10% (29.80%)

-108.40% (-65.50%)

-65.50% (-32.32%)

Return on Sales (ROS)

-474.80% (97.97%)

-23405.30%

-

-

Return on Invested Capital (ROIC)

-54.10% (8.77%)

-59.30% (44.32%)

-106.50% (65.80%)

-311.40% (27.26%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.53 (33.92%)

-2.32 (-4.55%)

-2.22 (56.06%)

-5.06 (40.94%)

Price to Sales Ratio (P/S)

9.29 (-98.65%)

686.61

-

-

Price to Book Ratio (P/B)

-2.19 (69.52%)

-7.18 (-15.09%)

-6.24 (-172.89%)

8.56 (72.91%)

Debt to Equity Ratio (D/E)

-2.49 (62.74%)

-6.69 (-108.80%)

-3.2 (-297.11%)

1.63 (213.10%)

Earnings Per Share (EPS)

-5.29 (-34.61%)

-3.93 (22.18%)

-5.05 (-29.82%)

-3.89 (-0.26%)

Sales Per Share (SPS)

0.88 (6630.77%)

0.01 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-4.22 (-55.67%)

-2.71 (28.05%)

-3.77 (6.19%)

-4.02 (-88.87%)

Book Value Per Share (BVPS)

-4.01 (-182.88%)

-1.42 (25.82%)

-1.91 (-198.10%)

1.95 (-66.65%)

Tangible Assets Book Value Per Share (TABVPS)

5.99 (-25.79%)

8.07 (91.53%)

4.21 (-17.70%)

5.12 (-42.36%)

Enterprise Value Over EBIT (EV/EBIT)

-3 (0.00%)

-3 (0.00%)

-3 (25.00%)

-4 (33.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.74 (17.79%)

-3.33 (-20.72%)

-2.76 (21.98%)

-3.54 (43.99%)

Asset Turnover

0.15 (5000.00%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

4.2 (-59.01%)

10.25 (67.51%)

6.12 (-37.94%)

9.86 (87.84%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$266,905,000 (-91.72%)

-$139,214,000 (5.66%)

-$147,571,000 (0.82%)

-$148,785,000 (-110.36%)

Enterprise Value (EV)

$716,482,317 (35.14%)

$530,187,498 (13.09%)

$468,807,993 (-3.01%)

$483,380,647 (-38.39%)

Earnings Before Tax (EBT)

-$334,326,000 (-65.84%)

-$201,592,000 (-1.96%)

-$197,723,000 (-37.42%)

-$143,883,000 (-11.48%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$261,522,000 (-64.43%)

-$159,049,000 (6.33%)

-$169,798,000 (-24.33%)

-$136,574,000 (-9.99%)

Invested Capital

$527,636,000 (22.81%)

$429,651,000 (126.99%)

$189,278,000 (141.33%)

$78,432,000 (6972.32%)

Working Capital

$274,406,000 (-23.49%)

$358,651,000 (167.10%)

$134,275,000 (-19.89%)

$167,605,000 (-28.93%)

Tangible Asset Value

$378,318,000 (-8.58%)

$413,842,000 (151.10%)

$164,810,000 (-13.00%)

$189,431,000 (-35.81%)

Market Capitalization

$555,224,317 (6.22%)

$522,715,498 (11.93%)

$466,985,993 (-24.43%)

$617,929,647 (-35.78%)

Average Equity

-$205,756,000 (-404.53%)

-$40,781,750 (-132.37%)

-$17,550,500 (-114.87%)

$118,026,000 (-36.87%)

Average Assets

$360,309,250 (35.98%)

$264,970,750 (45.33%)

$182,323,000 (-17.01%)

$219,687,500 (-15.69%)

Invested Capital Average

$485,225,000 (80.41%)

$268,957,000 (68.12%)

$159,979,250 (263.32%)

$44,032,000 (51.43%)

Shares

68,377,379 (19.43%)

57,252,519 (37.56%)

41,620,855 (32.49%)

31,414,827 (8.46%)